Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment
Key Highlights
- ➤Ainos (AIMD) completes VELDONA technology transfer, triggering $600,000 license payment
- ➤$600,000 payment due within 15 business days under the license agreement
- ➤VELDONA framework includes potential payments totaling $10 million
- ➤Ainos (AIMD) entitled to 25% of net sublicensing revenue
- ➤Delivery covers Sjögren's disease and thrombocytopenia clinical and regulatory materials
Expert Statements
Eddy Tsai, Chairman, President and Chief Executive Officer of Ainos
“We are delivering on the commitments we have communicated to shareholders.”
Eddy Tsai, Chairman, President and Chief Executive Officer of Ainos
“Following the delivery of 1,400 AI Nose systems to ASE, completion of the VELDONA technology transfer marks another tangible step in executing our agreements and realizing value from our assets.”
Eddy Tsai, Chairman, President and Chief Executive Officer of Ainos
“Our priorities remain clear: fulfill our commitments, collect contractual payments and allocate resources prudently as we advance Chemical Intelligence commercialization.”
HOUSTON, TX / ACCESS Newswire / September 30, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has completed the required data delivery and technology transfer under its VELDONA® license agreement, triggering a $600,000 initial license payment. The licensing partner confirmed completion in writing on September 29. Payment is due within 15 business days under the agreement.
The delivery includes clinical and regulatory materials for Sjögren's disease and thrombocytopenia, providing a foundation for the partner's continued development work in autoimmune and hematologic diseases. The initial payment is part of the previously announced potential $10 million licensing framework, which also includes conditional payments tied to the first sublicense and licenses for 15 additional indications. Ainos is separately entitled to 25% of net sublicensing revenue, as defined in the agreement.
Get started
Create a free account to read the full story.
